B-R 31 Ice Cream Co.,Ltd. (TYO:2268)

Revance Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2011	FY 2010
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	6,506	8,033	6,375	5,797	3,240	3,913
Cash & Short-Term Investments	6,506	8,033	6,375	5,797	3,240	3,913
Cash Growth	-1.69%	26.01%	9.97%	78.94%	-17.21%	21.02%
Accounts Receivable	1,557	2,804	1,700	1,849	3,036	2,773
Other Receivables	2,789	285	883	677	28.06	20.04
Receivables	4,346	3,089	2,583	2,526	3,064	2,793
Inventory	3,572	2,831	2,531	1,847	1,194	983.89
Prepaid Expenses	603	432	312	300	134.71	82.72
Other Current Assets	203	163	187	189	42.33	76.68
Total Current Assets	15,230	14,548	11,988	10,659	7,769	7,981
Property, Plant & Equipment	9,691	8,132	5,970	5,736	3,676	2,826
Long-Term Investments	2,800	2,710	2,532	2,688	24.95	25.67
Goodwill	182	208	205	209	-	-
Other Intangible Assets	504	509	460	411	211.95	233.2
Long-Term Deferred Tax Assets	204	206	194	255	132.96	116.81
Other Long-Term Assets	2	1	2	2	2,775	2,514
Total Assets	28,613	26,314	21,351	19,960	14,601	13,728
Accounts Payable	1,075	837	842	656	1,740	1,722
Accrued Expenses	104	156	145	109	114.56	118.5
Current Portion of Long-Term Debt	375	430	230	230	-	-
Current Income Taxes Payable	5,682	4,820	3,410	3,148	566.66	812.79
Current Unearned Revenue	-	-	-	-	540.77	295.53
Other Current Liabilities	3,102	2,470	2,194	2,089	165.5	223.2
Total Current Liabilities	10,338	8,713	6,821	6,232	3,128	3,172
Long-Term Debt	1,873	2,034	514	744	-	-
Long-Term Deferred Tax Liabilities	38	42	38	10	-	-
Other Long-Term Liabilities	1,832	1,747	1,495	1,444	1,172	1,010
Total Liabilities	14,240	12,680	8,981	8,563	4,508	4,368
Common Stock	735	735	735	735	735.29	735.29
Additional Paid-In Capital	241	241	241	241	241.08	241.08
Retained Earnings	13,215	12,413	11,255	10,390	9,145	8,431
Treasury Stock	-17	-17	-17	-17	-16.89	-16.79
Comprehensive Income & Other	199	262	156	48	-11.95	-29.42
Shareholders' Equity	14,373	13,634	12,370	11,397	10,092	9,361
Total Liabilities & Equity	28,613	26,314	21,351	19,960	14,601	13,728
Total Debt	2,248	2,464	744	974	-	-
Net Cash (Debt)	4,258	5,569	5,631	4,823	3,240	3,913
Net Cash Growth	-28.90%	-1.10%	16.75%	48.87%	-17.21%	21.02%
Net Cash Per Share	441.89	577.95	584.38	500.53	336.21	406.07
Filing Date Shares Outstanding	9.64	9.64	9.64	9.64	9.64	9.64
Total Common Shares Outstanding	9.64	9.64	9.64	9.64	9.64	9.64
Working Capital	4,892	5,835	5,167	4,427	4,641	4,809
Book Value Per Share	1491.62	1414.93	1283.75	1182.77	1047.34	971.45
Tangible Book Value	13,687	12,917	11,705	10,777	9,880	9,128
Tangible Book Value Per Share	1420.43	1340.52	1214.74	1118.43	1025.35	947.24
Land	-	-	-	-	695.36	226.36
Buildings	-	-	-	-	1,718	1,691
Machinery	-	-	-	-	3,031	2,805
Construction In Progress	-	-	-	-	268.23	117.68
Leasehold Improvements	-	-	-	-	2,882	2,612

Source: S&P Global Market Intelligence. Standard template. Financial Sources.